1. Home
  2. MOV vs NBY Comparison

MOV vs NBY Comparison

Compare MOV & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Movado Group Inc.

MOV

Movado Group Inc.

HOLD

Current Price

$22.35

Market Cap

481.7M

ML Signal

HOLD

Logo NovaBay Pharmaceuticals Inc.

NBY

NovaBay Pharmaceuticals Inc.

HOLD

Current Price

$2.00

Market Cap

398.2M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
MOV
NBY
Founded
1961
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Specialties
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
481.7M
398.2M
IPO Year
1993
2007

Fundamental Metrics

Financial Performance
Metric
MOV
NBY
Price
$22.35
$2.00
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$31.50
N/A
AVG Volume (30 Days)
132.8K
2.2M
Earning Date
11-25-2025
11-07-2025
Dividend Yield
6.19%
N/A
EPS Growth
27.72
N/A
EPS
0.97
0.47
Revenue
$661,205,000.00
$10,302,000.00
Revenue This Year
$2.19
$23.91
Revenue Next Year
$0.89
$32.05
P/E Ratio
$23.31
$92.21
Revenue Growth
2.78
390.34
52 Week Low
$12.85
$0.46
52 Week High
$23.06
$19.95

Technical Indicators

Market Signals
Indicator
MOV
NBY
Relative Strength Index (RSI) 55.22 38.23
Support Level $22.14 $1.80
Resistance Level $22.91 $18.40
Average True Range (ATR) 0.66 3.07
MACD -0.05 -1.35
Stochastic Oscillator 50.35 1.10

Price Performance

Historical Comparison
MOV
NBY

About MOV Movado Group Inc.

Movado Group Inc designs, develops, sources, markets, and distributes fine watches in the United States and internationally. It operates through the Watch and Accessory Brands and Company Stores segment. The Watch and Accessory Brands segment includes the designing, manufacturing, and distribution of watches and, to a lesser extent, jewelry and other accessories of quality owned brands and licensed brands. Its Company Stores segment includes the company's retail outlet locations in the United States and Canada. It generates maximum revenue from the Watch and Accessory Brands segment. Geographically, it derives the majority of its revenue from its international locations.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Share on Social Networks: